‘Shock and awe’: 200% Trump tariffs on pharma soon? US faces risk of drug shortages, steep prices

US President Trump’s proposed tariffs on pharmaceutical imports, potentially reaching 200%, aim to lower drug costs but could backfire. Experts warn of increased prices, supply chain disruptions, and reduced access to affordable generics.